Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock.
暂无分享,去创建一个
D. Tweardy | T. Billiar | Z. Meng | K. Dyer | K. F. Dyer | Zhi Hong Meng
[1] D. Tweardy,et al. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. , 2000, Shock.
[2] G. Ciliberto,et al. IL‐6 knock‐out mice exhibit resistance to splanchnic artery occlusion shock , 1999, Journal of leukocyte biology.
[3] P. Patterson,et al. Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury , 1999, Stem cells.
[4] Stéphanie Portet,et al. Quantitative analysis of cytokeratin network topology in the MCF7 cell line. , 1999, Cytometry.
[5] H. Noda,et al. Increased Serum Interleukin-8: Correlation with Poor Prognosis in Patients with Postoperative Multiple Organ Failure , 1998, World Journal of Surgery.
[6] Simon C Watkins,et al. Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[7] Kristine L. Danowski,et al. IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. , 1998, Journal of immunology.
[8] E. Moore,et al. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. , 1998, The Journal of surgical research.
[9] A. Peitzman,et al. Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.
[10] G. Kollias,et al. Interleukin 6 Is Required for the Development of Collagen-induced Arthritis , 1998, The Journal of experimental medicine.
[11] P. Clavien,et al. Interleukin‐6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent , 1997, Hepatology.
[12] Simon C Watkins,et al. Hemorrhagic shock induces G-CSF expression in bronchial epithelium. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[13] G. Ciliberto,et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.
[14] N. Ida,et al. Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[15] S. Dalrymple,et al. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection , 1996, Infection and immunity.
[16] B. Barton,et al. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model , 1996, Infection and immunity.
[17] T. Billiar,et al. Hepatic inducible nitric oxide synthase: regulation and function. , 1995, Biochemical Society transactions.
[18] H. Tilg,et al. Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy. , 1995, Cytokine.
[19] S. Dalrymple,et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia , 1995, Infection and immunity.
[20] M. Monden,et al. Changes in serum granulocyte colony-stimulating factor (G-CSF) and interleukin 6 (IL-6) after surgical intervention. , 1995, Research communications in molecular pathology and pharmacology.
[21] T. Maniatis,et al. NF-κB: A lesson in family values , 1995, Cell.
[22] G. Fantuzzi,et al. Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.
[23] I. Campbell,et al. Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. , 1994, The American journal of pathology.
[24] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[25] G. Ciliberto,et al. Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.
[26] B. Barton,et al. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model , 1993, Infection and immunity.
[27] B. Cochran,et al. The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter. , 1990, The EMBO journal.
[28] J. Vilček,et al. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.
[29] M. Sozmen,et al. Quantitation of histochemical staining of salivary gland mucin using image analysis in cats and dogs. , 1999, Veterinary research.
[30] D. Tweardy,et al. Rapid and simultaneous activation of Stat3 and production of interleukin 6 in resuscitated hemorrhagic shock , 1999, Archives of Orthopaedic and Trauma Surgery.
[31] G. Ciliberto,et al. Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. , 1998, Cytokine.
[32] J. Dipersio. Colony-stimulating factors: enhancement of effector cell function. , 1990, Cancer surveys.